Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Molecular Cancer Therapeutics
|
June 5, 2013
Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma
Barbara Nuvoli, Rossella Galati
Oncotarget
|
June 17, 2015
Reactive oxygen species a double-edged sword for mesothelioma
Serena Benedetti, Barbara Nuvoli, Simona Catalani, et al.
Free Radical Biology & Medicine
|
December 13, 2017
Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane
Barbara Nuvoli, Emanuela Camera, Arianna Mastrofrancesco, et al.
Oncotarget
|
June 21, 2016
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models
Barbara Nuvoli, Andrea Sacconi, Giancarlo Cortese, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
February 23, 2017
Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir
Simona Catalani, Francesco Palma, Serafina Battistelli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 7, 2014
CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
Barbara Nuvoli, Raffaela Santoro, Simona Catalani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 18, 2021
Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities
Barbara Nuvoli, Barbara Antoniani, Roberta Libener, et al.
Molecular Cancer
|
March 25, 2014
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
Barbara Nuvoli, Sabrina Germoni, Carlotta Morosetti, et al.
Therapeutic Advances in Medical Oncology
|
October 31, 2019
The effect of CELLFOOD<sup>TM</sup> on radiotherapy or combined chemoradiotherapy: preclinical evidence
Barbara Nuvoli, Bruno Amadio, Giancarlo Cortese, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 11, 2013
Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines
Simona Catalani, Valentina Carbonaro, Francesco Palma, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Molecular Cancer Therapeutics
|
June 5, 2013
Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma
Barbara Nuvoli, Rossella Galati
Oncotarget
|
June 17, 2015
Reactive oxygen species a double-edged sword for mesothelioma
Serena Benedetti, Barbara Nuvoli, Simona Catalani, et al.
Free Radical Biology & Medicine
|
December 13, 2017
Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane
Barbara Nuvoli, Emanuela Camera, Arianna Mastrofrancesco, et al.
Oncotarget
|
June 21, 2016
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models
Barbara Nuvoli, Andrea Sacconi, Giancarlo Cortese, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
February 23, 2017
Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir
Simona Catalani, Francesco Palma, Serafina Battistelli, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 7, 2014
CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
Barbara Nuvoli, Raffaela Santoro, Simona Catalani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 18, 2021
Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities
Barbara Nuvoli, Barbara Antoniani, Roberta Libener, et al.
Molecular Cancer
|
March 25, 2014
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
Barbara Nuvoli, Sabrina Germoni, Carlotta Morosetti, et al.
Therapeutic Advances in Medical Oncology
|
October 31, 2019
The effect of CELLFOOD<sup>TM</sup> on radiotherapy or combined chemoradiotherapy: preclinical evidence
Barbara Nuvoli, Bruno Amadio, Giancarlo Cortese, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 11, 2013
Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines
Simona Catalani, Valentina Carbonaro, Francesco Palma, et al.
Page
of 2